ID
18113
Description
Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00250874
Link
https://clinicaltrials.gov/show/NCT00250874
Keywords
Versions (1)
- 10/20/16 10/20/16 -
Uploaded on
October 20, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Metastatic Breast Cancer NCT00250874
Eligibility Metastatic Breast Cancer NCT00250874
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
Heart Diseases
Data type
boolean
Alias
- UMLS CUI [1]
- C0018799
Description
Liver disease Severe | Kidney Disease Severe
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0023895
- UMLS CUI [1,2]
- C0205082
- UMLS CUI [2,1]
- C0022658
- UMLS CUI [2,2]
- C0205082
Description
Metastatic malignant neoplasm to brain
Data type
boolean
Alias
- UMLS CUI [1]
- C0220650
Description
Medical contraindication Adrenal Cortex Hormones Premedication
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0001617
- UMLS CUI [1,3]
- C0033045
Description
Communicable Diseases
Data type
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
Diabetes Mellitus, Insulin-Dependent
Data type
boolean
Alias
- UMLS CUI [1]
- C0011854
Description
Malignant Neoplasms | Basal cell carcinoma Treated Adequate | Carcinoma in situ of uterine cervix Treated Adequate
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
- UMLS CUI [2,1]
- C0007117
- UMLS CUI [2,2]
- C1522326
- UMLS CUI [2,3]
- C0205411
- UMLS CUI [3,1]
- C0851140
- UMLS CUI [3,2]
- C1522326
- UMLS CUI [3,3]
- C0205411
Description
cancer treatment
Data type
boolean
Alias
- UMLS CUI [1]
- C0920425
Similar models
Eligibility Metastatic Breast Cancer NCT00250874
- StudyEvent: Eligibility
C1514559 (UMLS CUI [1,2])
C0162789 (UMLS CUI [2])
C0021044 (UMLS CUI [3])
C1514241 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C3495949 (UMLS CUI [2])
C3258246 (UMLS CUI [3])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
C0232164 (UMLS CUI [4])
C0013516 (UMLS CUI [5])
C0429706 (UMLS CUI [6])
C0013089 (UMLS CUI [2,1])
C2986497 (UMLS CUI [2,2])
C0014582 (UMLS CUI [3,1])
C2986497 (UMLS CUI [3,2])
C0205082 (UMLS CUI [1,2])
C0022658 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0001617 (UMLS CUI [1,2])
C0033045 (UMLS CUI [1,3])
C0007117 (UMLS CUI [2,1])
C1522326 (UMLS CUI [2,2])
C0205411 (UMLS CUI [2,3])
C0851140 (UMLS CUI [3,1])
C1522326 (UMLS CUI [3,2])
C0205411 (UMLS CUI [3,3])